Page 233 - Cardiac Nursing
P. 233

/09
                                /09
                                   1
                             6
                              /29
                              /29
                                   1
                                     7 P
                                        M
                                        M
                                   1:1
                                   1:1
                                     7 P
                      4-2
                        10.
                        10.
                    20
                    20
                      4-2
                          q
                           xd
                              6
                             6
                          q
                          q
                           xd
                                          Pa
                                                  ara
                                                  ara
                                                   a
                                                  t
                                                  t
                                                  ara
                                                   a
                                                    In
                                                      c.
                                                      c.
                                                   a
                                                   a
                                                    In
                                           g
                                            e 2
                                            e 2
                                          Pa
                                           g
                                           g
                                              09
                                                 p
                                                 p
                                                 p
                                              09
                                                A
                                                A
         LWB K34 0-c 09_ p p pp204-210.qxd  6/29/09  11:17 PM  Page 209 Aptara Inc.
               0-c
            K34
         LWB
         LWBK340-c09_
                 09_
                                                                    C HAPTER  9 / Physiologic Adaptations With Aging  209
                     As a result of changes in airway closure, diffusing capacity,  The limited ability of the kidney to regulate salt balance is
                   lung volumes, and lung structure, a lower arterial oxygen tension  compounded by changes in water regulation. The aging kidney
                   is seen in older adults. The arterial oxygen (Pa O2 ) decreases and  exhibits a modest age-related impairment in the ability to dilute
                   alveolar–arterial oxygen difference (A a O2 ) widens, whereas arte-  urine and excrete a water load. Inability to dilute urine maximally
                   rial carbon dioxide (Pa CO2 ) and pH remain unchanged.  is related to decreased GFR and an inability to suppress antidi-
                     In summary, although the lung undergoes some structural and  uretic hormone. The ability to concentrate urine declines moder-
                   functional changes, the nondiseased respiratory system continues  ately also, with the usual value specific gravity of 1.032 decreasing
                   to be capable of supporting daily function throughout life. The ef-  to 1.024 at age 80 years. 25  Therefore, the older person has more
                   fect of changes in the respiratory system may become evident un-  difficulty retaining fluid when it is necessary, as in situations of de-
                   der situations of high physiologic demand.          creased circulating fluid volume (e.g., dehydration), and in ex-
                                                                       creting fluid, as in situations of excess circulating fluid volume
                                                                       (e.g., congestive heart failure).
                      RENAL CHANGES                                      Although baseline homeostasis of fluids and electrolytes is
                                                                       maintained with normal aging, there is a progressive loss of renal
                   The kidney is an organ with complex functions that are intimately  reserve. Vitamin D hydroxylation in the kidney is decreased and
                   related with other organ systems, such as the cardiovascular, en-  may contribute to a decreased intestinal absorption of calcium.
                   docrine, and neurological systems. In discussing the aging kidney,  Decreased renal reserve manifests in older patients’ vulnerability
                   changes are discussed as they relate to intrinsic changes in the kid-  to renal failure during acute illness. There are many functions of
                   ney as well as those adaptive changes that result from the effects  the kidney (e.g., erythropoietin production, hormone metabo-
                   of other systems.                                   lism) that have yet to be thoroughly studied. Of those changes
                                                                       that have been described, the clinical effects on drugs and their ex-
                   Structural Changes                                  cretion and on fluid balance are of primary importance.
                   The volume and weight of the kidney reach maximum in the
                   third decade of life, start to decline during the fourth decade, and  HEPATIC CHANGES
                   continue to decline throughout the remainder of the lifespan.
                   Most of the decline in volume and weight is in the cortex, with a  Structural Changes
                   steady decline in the number of nephrons. Renal arteries undergo
                   age-related thickening, producing a decline in renal blood flow  The proportion of liver to body weight remains constant through
                                                                                                              26
                   and an increase in vascular resistance with age.    middle age and decreases gradually after age 70 years.  Liver his-
                                                                       tology in older adults shows more lipofuscin pigment and giant
                                                                       hepatocytes than in younger individuals. In healthy subjects, liver
                   Functional Changes                                  size, blood flow, and perfusion decrease by 30% to 40% between
                                                                       the third and tenth decade. 26
                   Average renal blood flow decreases approximately 10% per
                   decade, and the majority of older adults lose approximately 10%
                   of glomerular filtration rate (GFR) per decade after the fourth  Functional Changes
                   decade. The reduced renal blood flow and decreased number of  There is no change in level of serum bilirubin, aminotransferases,
                   nephrons contribute to the reduction of GFR. Because of the de-  or alkaline phosphatase with aging. Age-related change in liver
                   crease in muscle mass with aging, increased serum creatinine does  function is small and, with the exception of some enzymes in-
                   not correspond with reduced GFR. Creatinine clearance, not  volved in drug metabolism, is not clinically significant. There is a
                   serum creatinine, should be the criterion for assessing renal func-  decrease in the hepatic clearance of drugs, particularly those that
                   tion in older people. The Cockcroft–Gault equation predicts cre-  have a low-extraction ratio and whose elimination is dependent
                   atinine clearance from serum creatinine. For men: creatinine  on the cytochrome P450 system.
                   clearance   (140 – age) (weight in kg)/(72   serum creatinine
                   measured in mg/dL). The results are adjusted for women by mul-
                   tiplying by 0.85.                                     EFFECTS OF AGING ON
                     The clinical importance of this formula is apparent when de-  PHARMACOKINETICS
                   terminations about kidney function and appropriate drug dosage
                   need to be made. The steady decline in renal function impairs the  Drug Absorption
                   ability of the kidney to excrete a salt or water load and decreases
                   the renal clearance of those medications normally removed by the  Little is known about absorption of oral drugs from the intestines,
                   kidney. 24                                          but it seems to be mildly decreased or unchanged with age. Ab-
                     The aging kidney’s tendency to lose salt is related to nephron  sorption appears to be the pharmacokinetic parameter least af-
                   loss, with increased osmotic load per nephron leading to mild os-  fected by advancing age.
                   motic diuresis and the age-related changes in the renin–aldos-
                   terone system. Lower levels of renin (decreased by 30% to 50% in  Drug Distribution
                   older adults) are related to 30% to 50% reductions in plasma con-
                   centration of aldosterone. When these lower levels are combined  Decreased serum albumin concentration is linked to decreased
                   with the decreased GFR, older people are at risk for expansion of  binding capacity of drugs. Drugs that are bound are inactive in
                   extracellular fluid volume when faced with an acute salt load  terms of therapeutic effect. Unbound, or free, drug is free to exert
                   (from diet, drugs, or intravenous fluids).           therapeutic effects. This is one reason why a smaller dosage of
   228   229   230   231   232   233   234   235   236   237   238